Paolo Marchetti

Sapienza University of Rome

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Marina BORRO

Associate Professor - Biochemistry

Sapienza University of Rome

ITALY

View details

eriseld krasniqi

ITALY

View details

Alessandro Corsi

Sapienza University

ITALY

View details

Cira di Gioia

Sapienza University of Rome

ITALY

View details

Nicola Tinari

University of Chieti-Pescara

ITALY

View details

Caterina MARCHIO'

Associate Professor of Pathology

University of Turin

ITALY

View details

Vincenzo Tombolini

Full Professor

Università degli Studi di Roma La Sapienza Dipartimento di Scienze Statistiche

ITALY

View details

francesca sperati

Istituto San Gallicano

ITALY

View details

Silvia MEZI

Aggregate professor

Sapienza University of Rome

ITALY

View details

Robert Preissner

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paolo Marchetti

Research Interests

Explore related searches

Contact this professor

Articles (10)

The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma

The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile

The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study

Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement

A Regional Survey on Merkel Cell Carcinoma: A Plea for Uniform Patient Journey Modeling and Diagnostic–Therapeutic Pathway

Patients’ Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study

A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma

Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study

Collaborators (10)

Marina BORRO

eriseld krasniqi

Alessandro Corsi

Cira di Gioia

Nicola Tinari

Caterina MARCHIO'

Vincenzo Tombolini

francesca sperati

Silvia MEZI

Robert Preissner

Make your next move.

Paolo Marchetti

Research Interests

Explore related searches

Contact this professor

Articles (10)

The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma

The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO Study

Definition of High-Risk Early Hormone-Positive HER2&minus;Negative Breast Cancer: A Consensus Review

Genomic and Immune Approach in Platinum Refractory HPV-Negative Head and Neck Squamous Cell Carcinoma Patients Treated with Immunotherapy: A Novel Combined Profile

The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study

Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement

A Regional Survey on Merkel Cell Carcinoma: A Plea for Uniform Patient Journey Modeling and Diagnostic–Therapeutic Pathway

Patients’ Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS Study

A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma

Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study

Collaborators (10)

Marina BORRO

eriseld krasniqi

Alessandro Corsi

Cira di Gioia

Nicola Tinari

Caterina MARCHIO'

Vincenzo Tombolini

francesca sperati

Silvia MEZI

Robert Preissner

Make your next move.

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review